BlackRock Investment Management, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 131 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,849,000
+47.4%
85,043
+17.1%
0.00%
+50.0%
Q3 2016$1,933,000
+20.9%
72,626
+0.1%
0.00%0.0%
Q2 2016$1,599,000
-14.5%
72,530
+13.9%
0.00%0.0%
Q1 2016$1,871,000
-9.3%
63,694
+1.9%
0.00%
-33.3%
Q4 2015$2,063,000
-8.4%
62,485
+0.3%
0.00%0.0%
Q3 2015$2,252,000
-11.9%
62,314
+9.7%
0.00%0.0%
Q2 2015$2,556,000
+175.1%
56,809
+87.2%
0.00%
+200.0%
Q1 2015$929,000
-39.0%
30,342
+1.2%
0.00%
-50.0%
Q4 2014$1,524,000
+28.2%
29,979
-0.3%
0.00%0.0%
Q3 2014$1,189,000
-7.7%
30,057
+0.5%
0.00%0.0%
Q2 2014$1,288,000
+211.9%
29,914
+189.7%
0.00%
+100.0%
Q1 2014$413,000
+49.6%
10,326
+2.1%
0.00%
Q4 2013$276,000
+19.0%
10,118
-0.0%
0.00%
Q3 2013$232,000
+44.1%
10,123
+11.4%
0.00%
Q2 2013$161,0009,0880.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 936,777$53,218,00016.69%
Fairmount Funds Management LLC 316,952$18,006,0006.55%
ARMISTICE CAPITAL, LLC 1,836,000$104,303,0001.77%
Soleus Capital Management, L.P. 182,400$10,362,0001.62%
Portland Global Advisors LLC 62,635$3,558,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 40,000$2,263,0000.55%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$113,336,0000.53%
Yorktown Management & Research Co Inc 10,400$591,0000.44%
Hennion & Walsh Asset Management, Inc. 120,240$6,831,0000.36%
Virtus ETF Advisers LLC 9,599$545,0000.24%
View complete list of ENANTA PHARMACEUTICALS INC shareholders